EP-282

N/A

Report date: 2025/03/19 14:04:45
NME

Base Information

Drug NameEP-282
Drug Alias NameEP-282
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFree fatty acid receptor 2 agonists
TargetsFree fatty acid receptor 2
Therapy Area/IndicationsInflammationGastrointestinal DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesEPICS Therapeutics SA
China Registration ClassN/A

Develop Information

Active CompaniesEPICS Therapeutics SA
Inactive CompaniesN/A
Active IndicationsInflammationGastrointestinal DiseasesNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A